CI-922 — A novel, potent antiallergic compound — I. Inhibition of mediator release in vitro
- 1 January 1987
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 9 (1) , 41-49
- https://doi.org/10.1016/0192-0561(87)90109-3
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- CI-922—A novel, potent antiallergic compound — II. Activity in animal models of allergyInternational Journal of Immunopharmacology, 1987
- Immunologic studies in allergen-induced late-phase asthmatic reactionsJournal of Allergy and Clinical Immunology, 1984
- Binding of leukotrienes C4 and D4 to membranes from guinea pig lung: Regulation by ions and gaunine nucleotidesLife Sciences, 1983
- Effects of sodium cromoglycate analogues on the immunological release of slow reacting substance of anaphylaxis and histamine from human and guinea-pig lung in vitroJournal of Pharmacy and Pharmacology, 1982
- THE ACTIVITY OF SODIUM CROMOGLYCATE ANALOGUES IN HUMAN LUNG in vitro: A COMPARISON WITH RAT PASSIVE CUTANEOUS ANAPHYLAXIS AND CLINICAL EFFICACYBritish Journal of Pharmacology, 1980
- Inhibition of cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonistBiochemical Pharmacology, 1978
- New orally effective chromone derivatives for the treatment of asthmaInflammation Research, 1977
- Selective Inhibitor of Slow Reacting Substance of AnaphylaxisNature New Biology, 1973
- BRONCHOCONSTRICTOR ACTION AND ANTAGONISM OF A SLOW‐REACTING SUBSTANCE FROM ANAPHYLAXIS OF GUINEA‐PIG ISOLATED LUNGBritish Journal of Pharmacology and Chemotherapy, 1964
- The release of histamine and formation of a slow‐reacting substance (SRS‐A) during anaphylactic shockThe Journal of Physiology, 1960